These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14720303)

  • 1. Imaging genome abnormalities in cancer research.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye CJ
    Cell Chromosome; 2004 Jan; 3(1):1. PubMed ID: 14720303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stochastic cancer progression driven by non-clonal chromosome aberrations.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
    J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal and non-clonal chromosome aberrations and genome variation and aberration.
    Heng HH; Liu G; Bremer S; Ye KJ; Stevens J; Ye CJ
    Genome; 2006 Mar; 49(3):195-204. PubMed ID: 16604101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Importance of Monitoring Non-clonal Chromosome Aberrations (NCCAs) in Cancer Research.
    Heng E; Thanedar S; Heng HH
    Methods Mol Biol; 2024; 2825():79-111. PubMed ID: 38913304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?
    Heng HH; Regan SM; Liu G; Ye CJ
    Mol Cytogenet; 2016; 9():15. PubMed ID: 26877768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer progression by non-clonal chromosome aberrations.
    Heng HH; Bremer SW; Stevens J; Ye KJ; Miller F; Liu G; Ye CJ
    J Cell Biochem; 2006 Aug; 98(6):1424-35. PubMed ID: 16676347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights in the Cytogenetic Practice: Karyotypic Chaos, Non-Clonal Chromosomal Alterations and Chromosomal Instability in Human Cancer and Therapy Response.
    Rangel N; Forero-Castro M; Rondón-Lagos M
    Genes (Basel); 2017 Jun; 8(6):. PubMed ID: 28587191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Karyotype heterogeneity and unclassified chromosomal abnormalities.
    Heng HH; Liu G; Stevens JB; Abdallah BY; Horne SD; Ye KJ; Bremer SW; Chowdhury SK; Ye CJ
    Cytogenet Genome Res; 2013; 139(3):144-57. PubMed ID: 23571381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dynamics of cancer chromosomes and genomes.
    Ye CJ; Liu G; Bremer SW; Heng HH
    Cytogenet Genome Res; 2007; 118(2-4):237-46. PubMed ID: 18000376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer.
    Yoon DS; Wersto RP; Zhou W; Chrest FJ; Garrett ES; Kwon TK; Gabrielson E
    Am J Pathol; 2002 Aug; 161(2):391-7. PubMed ID: 12163363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic mechanisms and measurement of structural and numerical instability in cancer cells.
    Bayani J; Selvarajah S; Maire G; Vukovic B; Al-Romaih K; Zielenska M; Squire JA
    Semin Cancer Biol; 2007 Feb; 17(1):5-18. PubMed ID: 17126026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G2 Premature Chromosome Condensation/Chromosome Aberration Assay: Drug-Induced Premature Chromosome Condensation (PCC) Protocols and Cytogenetic Approaches in Mitotic Chromosome and Interphase Chromatin for Radiation Biology.
    Gotoh E
    Methods Mol Biol; 2019; 1984():47-60. PubMed ID: 31267419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on chromosome aberration induction: what can they tell us about DNA repair?
    Bailey SM; Bedford JS
    DNA Repair (Amst); 2006 Sep; 5(9-10):1171-81. PubMed ID: 16814619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetic applications in analysis of the cancer genome.
    Rao PH; Nandula SV; Murty VV
    Methods Mol Biol; 2007; 383():165-85. PubMed ID: 18217685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of chromosomal abnormalities in solid tumors of humans].
    Limon J; Mitelman F
    Pol J Pathol; 1994; 45(1):1-15. PubMed ID: 8177615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is Karyotype Coding and Why Is Genomic Topology Important for Cancer and Evolution?
    Ye CJ; Stilgenbauer L; Moy A; Liu G; Heng HH
    Front Genet; 2019; 10():1082. PubMed ID: 31737054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors.
    Salas C; Niembro A; Lozano V; Gallardo E; Molina B; Sánchez S; Ramos S; Carnevale A; Pérez-Vera P; Rivera Luna R; Frias S
    Environ Mol Mutagen; 2012 May; 53(4):271-80. PubMed ID: 22434555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyotypic Flexibility of the Complex Cancer Genome and the Role of Polyploidization in Maintenance of Structural Integrity of Cancer Chromosomes.
    Raftopoulou C; Roumelioti FM; Dragona E; Gimelli S; Sloan-Béna F; Gorgoulis V; Antonarakis SE; Gagos S
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32150835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
    Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
    Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision in chromosome identification with leads in molecular cytogenetics: An illustrated review.
    Dutta UR
    J Pediatr Genet; 2014 Mar; 3(1):1-7. PubMed ID: 27625861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.